Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma × CP protocol × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Neoplasms, Unknown Primary 2 Lung Neoplasms 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Unresectable Stage III NSCLC 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Penile Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Male Urogenital Diseases 1 First-line Advanced NSCLC Patients 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Cisplatin 18 Gemcitabine 12 pembrolizumab 11 Paclitaxel 11 Carboplatin 11 Fluorouracil 7 Specimen Handling 6 Sunitinib 5 Radiotherapy 5 Platinum 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Everolimus 5 Docetaxel 5 durvalumab 4 Radiotherapy, Intensity-Modulated 4 Pemetrexed 4 Oxaliplatin 4 Drug Therapy 4 Cyclophosphamide 4 Cetuximab 4 Capecitabine 4 1,2-diaminocyclohexaneplatinum II citrate 4 epothilone B 3 cemiplimab 3 atezolizumab 3 anlotinib 3 Panitumumab 3 Chemoradiotherapy 3 Celecoxib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00894569 2009-05-14

PACET-CUP

Heidelberg University

Phase 2 Unknown

Carcinoma, Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡